Metraipolis › archive › dc_e96f7be25ea7

Engineering immunity in osteosarcoma: nanomedicine strategies for overcoming immune evasion — Europe PMC PMID:42602401

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42602401
DOI
10.3389/fimmu.2026.1897106
License (as archived)
solo-consultazione
Archived
2026-10-17T06:37:32.799Z
SHA-256 of the archived text
9b7564b9ad7ae2ef15eeee66110b29fd8ed6aa0cbb03156fef1e4f82f8ac9b60
Stable URL of this page
https://metraipolis.com/documento/dc_e96f7be25ea7

How to cite

Engineering immunity in osteosarcoma: nanomedicine strategies for overcoming immune evasion — Europe PMC PMID:42602401 — Europe PMC (en), https://europepmc.org/article/MED/42602401 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e96f7be25ea7 (Metraipolis archive dc_e96f7be25ea7, sha256 9b7564b9ad7ae2ef15eeee66110b29fd8ed6aa0cbb03156fef1e4f82f8ac9b60)
BibTeX
@misc{dce96f7be25ea7,
  title = {Engineering immunity in osteosarcoma: nanomedicine strategies for overcoming immune evasion — Europe PMC PMID:42602401},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42602401},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e96f7be25ea7; sha256 9b7564b9ad7ae2ef15eeee66110b29fd8ed6aa0cbb03156fef1e4f82f8ac9b60},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42602401. Agents can read the archived copy with the MCP tool read_document.